Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.

Autor: Brockwell NK; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia., Rautela J; 4The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC Australia.; 5Department of Medical Biology, University of Melbourne, Melbourne, VIC Australia., Owen KL; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia., Gearing LJ; 6Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC Australia.; 7Department of Molecular and Translational Science, Monash University, Clayton, VIC Australia., Deb S; Anatpath, Gardenvale, VIC Australia., Harvey K; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia., Spurling A; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia., Zanker D; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia., Chan CL; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia., Cumming HE; 6Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC Australia.; 7Department of Molecular and Translational Science, Monash University, Clayton, VIC Australia., Deng N; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia., Zakhour JM; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia., Duivenvoorden HM; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia., Robinson T; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia., Harris M; 10Monash Health, Clayton, VIC Australia., White M; 10Monash Health, Clayton, VIC Australia., Fox J; 10Monash Health, Clayton, VIC Australia.; 11Monash Health School of Clinical Sciences, Monash University, Clayton, VIC Australia., Ooi C; 10Monash Health, Clayton, VIC Australia., Kumar B; 10Monash Health, Clayton, VIC Australia., Thomson J; Penninsula Health, Frankston, VIC Australia., Potasz N; Penninsula Health, Frankston, VIC Australia., Swarbrick A; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia., Hertzog PJ; 6Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC Australia.; 7Department of Molecular and Translational Science, Monash University, Clayton, VIC Australia., Molloy TJ; 13St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW Australia.; 14St Vincent's Centre for Applied Medical Research, Darlinghurst, NSW Australia., Toole SO; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia.; 15Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW Australia.; 16Sydney Medical School, University of Sydney, Sydney, NSW Australia.; Australian Clinical Labs, Bella Vista, NSW Australia., Ganju V; 6Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC Australia.; 7Department of Molecular and Translational Science, Monash University, Clayton, VIC Australia.; 10Monash Health, Clayton, VIC Australia., Parker BS; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia.

Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2019 Aug 29; Vol. 3, pp. 21. Date of Electronic Publication: 2019 Aug 29 (Print Publication: 2019).